Solutions to complement Company’s growing position in cell and gene therapy research and development WALTHAM, Mass. -- PerkinElmer, Inc. (NYSE: PKI) (“PerkinElmer”) is pleased to announce it has entered into an agreement to acquire SIRION Biotech GmbH, a leading, global provider of viral vector-based technologies that drive improved delivery performance for cell and gene therapies. The acquisition is [...]

WALTHAM, Mass. -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it has entered into an agreement to acquire Toulouse, France based Polymem S.A. (“Polymem”), a leading industrial expert in the development and manufacture of hollow fiber membranes and modules. Tony J. Hunt, President and CEO of Repligen, [...]

Launching the full range for biopharma analysis at the Agilent InfinityLab LC VirtualConference SANTA CLARA, Calif. -- Agilent Technologies Inc. (NYSE: A) today announced the launch of three InfinityLab Bio LC systems specifically developed to meet the needs of the biopharma industry. The release is central to the Agilent portfolio of complete Bio LC solutions, featuring instruments, columns, [...]

Launch of world’s first Duchenne data hub, CureDuchenne Link™, driven by BCP technology, will improve access to critical data and help discover novel disease biomarkers BC Platforms (BCP), a global leader in healthcare data management, analytics, and access and CureDuchenne, a leading global non-profit organisation focused on finding and funding a cure for Duchenne muscular dystrophy, today [...]

TUCSON, Ariz. -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced it has received the first commercial orders for its planned HTG Transcriptome Panel and has signed agreements with its first two Early Adopter Program (EAP) collaborators in Europe. HTG has now signed EAP agreements with [...]

SEATTLE --  NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the launch of the nCounter® Stem Cell Characterization Panel for the analysis and optimization of stem cell lines used in the development of potential novel therapeutics. Recent breakthroughs in stem cell therapy, regenerative medicine, [...]

NEWTON, Mass -- Molecular Loop Biosciences, Inc. , a company redefining the simplicity of targeted sequencing, announced today that its SARS-CoV-2 Research Sequencing Panel has been deployed by LabCorp(NYSE: LH), a leading global life sciences company, to help sequence thousands of complete coronavirus genomes each week from positive patient samples. This sequencing is being performed as part of a [...]

Technology Visionary will Offer Strategic Insight to Guide Ongoing Research & Development of Market Leading Organ-on-a-Chip Technology BOSTON, MA — Emulate Inc., a leading provider of next-generation in vitro models, today announced the appointment of Scott D. Kantor as Chief Financial Officer. Reporting to Jim Corbett, Chief Executive Officer, Scott will be responsible for strengthening the organization’s operational readiness [...]

Life sciences cloud leader’s unified platform now supports development of RNA-based treatments for previously ‘undruggable’ diseases SAN FRANCISCO, Calif. – Benchling, the leading life sciences cloud, today announced the launch of a digital solution for scientists to design, analyze, and develop complex RNA therapeutics in a unified R&D platform for the first time.  RNA therapeutics [...]

QIAprep&amp CRISPR Kit and Q-Primer Solutions expand QIAGEN portfolio for CRISPR applications Products are highly sensitive tools for characterizing the impact of CRISPR editing experiments Solutions combine liquid-based sample preparation with PCR detection and Sanger sequencing HILDEN, Germany, & GERMANTOWN, Md.--QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of QIAprep&amp CRISPR Kit and [...]